At a glance
- Computer system validation (CSV) is producing documented evidence that a system does what it is specified to do, accurately and repeatably, for its intended use. It is a risk-and-evidence discipline, not a paperwork ritual.
- It is required because regulated electronic records and the systems that hold them must be trustworthy. Part 11 and Annex 11 carry that expectation.
- Not every system needs the same validation. Risk to product quality and patient safety drives the rigor, and the GAMP 5 software categories let supplier-provided assurance scale your effort.
- The lifecycle follows the V-model (specify, build, verify), with IQ, OQ, and PQ as the verification stages. The detail lives in the deliverables and testing guides.
- CSV and CSA are not opposites: CSA is the FDA’s current, risk-based way of achieving the same assurance with less wasted effort. A small team should validate the right systems to the right depth.
If you are meeting computer system validation for the first time, or need to explain it internally, the search results tend to fail you in one of two ways: they dive straight into IQ/OQ/PQ mechanics and template downloads without establishing what “validated” even means, or they blur CSV with the newer FDA CSA shift and leave you unsure which world you are in. And almost all of them imply every system needs maximal validation.
This hub gives you the mental model first. It defines CSV plainly, explains why it is required, maps which systems actually need validating and to what rigor, sketches the lifecycle and the GAMP 5 risk-scaling idea, notes how the bar shifts across life-science sectors, and orients you on CSV versus CSA, before sending you to the detailed guides for protocols, testing, and the CSA guidance. The goal is that a lean team validates the right systems to the right depth, instead of being paralyzed by enterprise-grade rigor it does not need.
What is computer system validation (CSV)?
The one-sentence definition
Computer system validation is the process of producing documented evidence that a computerized system consistently does what it is specified to do, fit for its intended use, and can discern invalid or altered records. That is essentially the standard Part 11 sets for validation: ensuring accuracy, reliability, and consistent intended performance, and the ability to discern invalid or altered records (§ 11.10(a)).
CSV vs. casual “testing”, why evidence and traceability matter
Validation is not “we tried it and it worked.” Two things separate it from casual testing: documented, objective evidence (you can show, not just assert, that the system met its requirements), and traceability (every requirement maps to the evidence that verified it). Without those, you have an opinion about the system, not validation. The discipline is precisely the documentation and traceability that make the confidence defensible to an inspector.
What CSV means in pharma and clinical research
In pharma and clinical research, CSV applies to the computerized systems that create, hold, or process regulated data, EDC, eTMF, CTMS, laboratory and manufacturing systems, and the like. The aim is that the systems running regulated activities are trustworthy, so the data and decisions resting on them can be relied upon. ICH-aligned GCP reflects the same instinct, asking that computerised systems used in trials be fit for purpose, which is the clinical expression of “validated for intended use.” (The clinical-trial-specific obligations are covered in the GCP guides.)
Why is CSV required?
Where the expectation comes from
CSV is driven by the requirement that regulated electronic records, and the systems that produce them, be reliable and trustworthy. Two anchors, at altitude:
- 21 CFR Part 11 requires validation of systems used for regulated electronic records to ensure accuracy, reliability, and consistent intended performance (§ 11.10(a)).
- EU Annex 11 states that the application should be validated and the IT infrastructure qualified, with the extent of validation based on a justified, documented risk assessment (Principle and § 1).
Note the structure: the obligation to keep the record comes from an underlying predicate rule, and the electronic-records rules then require that the system holding it be validated. CSV is how you satisfy that requirement; it is not an end in itself. (For the predicate-rule logic, see the Part 11 explainer.)
Which systems actually need validating, GxP scope-mapping
Risk to product quality and patient safety drives the rigor
Not every system, and not to the same depth. The question is whether, and how much, a system’s failure could affect product quality, data integrity, or patient safety. A system that holds critical regulated data or drives a safety-relevant decision warrants serious validation; a system with no GxP impact may need little or none. EU Annex 11 makes the effort proportionate, tying the extent of validation to a justified, documented risk assessment of the system (§ 1).
The common trap: over-validating low-risk systems, under-documenting high-risk ones
The classic small-team failure modes are mirror images: pouring enterprise-grade validation into a low-risk tool while a genuinely high-risk system is thinly documented. Risk-based scope-mapping fixes both, put the effort where the risk is, and document the rationale either way.
The CSV lifecycle at a high level
The V-model: specify, build, verify against spec
CSV is usually organized around the V-model: you specify the system (requirements, then functional and design detail), build or configure it, then verify it against those specifications. The left arm specifies; the right arm verifies; each verification maps back to its specification. The full document set lives in the CSV deliverables guide.
Where IQ / OQ / PQ sit
The verification stages, one line each:
- IQ (Installation Qualification): the system is installed and configured correctly.
- OQ (Operational Qualification): it functions as specified.
- PQ (Performance Qualification): it performs correctly in real intended use.
These qualification stages are the industry-standard structure for the verification arm of the V-model; the deliverables and testing detail live in the CSV deliverables and CSV testing guides.
GAMP 5 software categories, letting risk size the effort
A practical industry tool for right-sizing is the GAMP 5 software category model (from ISPE, an industry body, not a regulator). It classifies software by type, from infrastructure and standard commercial products to configured products and custom applications, and scales expected validation effort accordingly, with more supplier-provided assurance and less bespoke work for standard products, and more rigor for custom code. Used well, GAMP 5 lets you leverage what the supplier has already done and concentrate your effort where your configuration and intended use create real risk. Treat it as industry best practice that operationalizes the regulators’ risk-based posture, not as a regulation itself.
How the validation bar shifts across life-science sectors
The same risk-and-evidence discipline applies across pharma, medical device, diagnostics, and biotech, but the specific predicate rules and the evidence bar differ by sector and product risk. A device manufacturer’s quality-system software sits under different predicate requirements than a clinical sponsor’s data systems, and a diagnostic’s bar differs again. The orienting point for a lean team: the principle (validate for intended use, proportionate to risk) is constant, but identify which predicate rules apply to your sector before assuming another sector’s exact expectations are yours. Do not exhaustively map every sector here; know that the bar is sector-specific.
CSV vs. CSA: a one-paragraph orientation
CSA (Computer Software Assurance) is not a replacement that makes CSV obsolete; it is the FDA’s current, risk-based articulation of how to achieve validation assurance with effort proportionate to risk, leading with critical thinking and scaling testing to intended use and impact. The underlying requirement for validated, reliable systems remains; CSA changes how you justify and scope the effort, encouraging you to stop spending high-risk rigor on low-risk software. For the full guidance arc and what changed, see the dedicated CSV/CSA guidance guide.
Where CSV applies in clinical project management software
For a clinical team, a practical question is which of your own tools need validating. A system that holds or processes regulated trial data or records is a validation candidate; the depth follows its risk. A clinical project management tool a small team uses for coordination is exactly the kind of system to assess on this basis. TrialTrack is one example of such a tool; as with any system, validating it for your intended use would be your responsibility, the tool does not provide validation and does not make a team compliant (any Part 11 capability is TrialTrack’s own claim). The discipline is the same: assess the risk, validate to the right depth, document the rationale.
Frequently asked questions
What is computer system validation? Producing documented, traceable evidence that a system consistently does what it is specified to do, fit for its intended use, and can discern invalid or altered records.
Why is CSV required? Because regulated electronic records and the systems holding them must be trustworthy. 21 CFR Part 11 (§ 11.10(a)) and EU Annex 11 require validation, driven by an underlying predicate rule’s record requirement.
Which systems need validating, and to what rigor? Those whose failure could affect product quality, data integrity, or patient safety, with rigor proportionate to that risk, per a documented risk assessment. Not every system, and not equally.
What are the GAMP 5 categories and why do they matter? An ISPE software-classification model that scales validation effort by software type and supplier-provided assurance, letting you avoid over-validating standard products and concentrate effort on real risk.
Is CSV the same as CSA? No, but they are not opposites. CSA is FDA’s current risk-based approach to achieving the same validation assurance with proportionate effort. The requirement for validated systems remains.
The bottom line
Computer system validation is a risk-and-evidence discipline: documented, traceable proof that a system does what it is specified to do for its intended use. It is required because regulated electronic records must be trustworthy, but it is not one-size-fits-all, risk to quality and patient safety drives the rigor, and GAMP 5 lets supplier assurance scale your effort. Learn the V-model and where IQ/OQ/PQ sit, understand that CSA is the current risk-based path to the same assurance, then validate the right systems to the right depth, and follow the deliverables, testing, and CSA guides for the detail.
Sources
Dejan Murko
Dejan is the co-founder of Mayet, building software for biotech and pharma teams.